Depression & Anxiety

Venue: The Hatton

Location: London, United Kingdom

Event Date/Time: May 12, 2003 End Date/Time: May 13, 2003
Registration Date: May 08, 2003
Report as Spam


Depression & Anxiety will cover the new directions in the treatment of depression and anxiety: specifically the role of: Nicotinics, GABAA receptors, the HPA axis and Substance P. In addition to this the conference will also cover:
· The role of Clinical Trials and how to improve clinical trial results in this complex industry
· Overcoming the problems of the placebo effect
· The role of co-morbidity in drug development
· The market dynamics, potential niches and entry strategies for the depression and anxiety industry
· Regulatory affairs: US & European
· Strategies to improve the antidepressant market and pipelines

This conference will appeal to people in the pharmaceutical industry, involved in drug discovery, clinical trials, regulations and marketing. It is designed to be attractive to academics and consultants in this field


The Hatton
Hatton Garden EC1
United Kingdom